These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37348270)

  • 41. The dawn of a new synthetic opioid era: the need for innovative interventions.
    Pardo B; Taylor J; Caulkins J; Reuter P; Kilmer B
    Addiction; 2021 Jun; 116(6):1304-1312. PubMed ID: 32869394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
    Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fentanyl contaminated "M30" pill overdoses in pediatric patients.
    Joynt PY; Wang GS
    Am J Emerg Med; 2021 Dec; 50():811.e3-811.e4. PubMed ID: 34030905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL
    Trials; 2020 Nov; 21(1):976. PubMed ID: 33243291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
    Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
    J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
    Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
    Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining opioid-involved overdose mortality trends prior to fentanyl: New York City, 2000-2015.
    Tuazon E; Kunins HV; Allen B; Paone D
    Drug Alcohol Depend; 2019 Dec; 205():107614. PubMed ID: 31689642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of illicit online sales of fentanyls via Twitter.
    Mackey TK; Kalyanam J
    F1000Res; 2017; 6():1937. PubMed ID: 29259769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants.
    Reed MK; Roth AM; Tabb LP; Groves AK; Lankenau SE
    Int J Drug Policy; 2021 Jun; 92():103147. PubMed ID: 33583679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE; Vervoordt A; Lieberman M
    Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "It's Also Pushed People to a New Level of Desperation:" COVID-19 Impacts on Experiences of Persons Who Use Illicit Opioids.
    Sweeney K; Daniulaityte R; Mendoza N; Ki S; Doebbeling B
    J Psychoactive Drugs; 2024; 56(1):127-134. PubMed ID: 36548869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age.
    Raheemullah A; Andruska N
    J Opioid Manag; 2019; 15(5):428-432. PubMed ID: 31849033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription Drug Histories among Drug Overdose Decedents in Delaware.
    Anderson TL; Wagner J; Qi G; Martin SS; O'Connell D; Donnelly E
    Subst Use Misuse; 2020; 55(11):1892-1899. PubMed ID: 32552308
    [No Abstract]   [Full Text] [Related]  

  • 59. The Opioid Crisis: Prevalence and Markets of Opioids.
    Gardner EA; McGrath SA; Dowling D; Bai D
    Forensic Sci Rev; 2022 Jan; 34(1):43-70. PubMed ID: 35105535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.